Information Library
Hear From the Experts - Market Access
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
Robert A. Pearlstein
March 25, 2009
Bob is a co-founder of Eidetics, and has over two decades of experience assessing commercial opportunities and creating product strategies for biopharma and medical device clients worldwide. -
George A. Mabry
March 25, 2009
George joined Eidetics in 1989 after a successful career in consumer and industrial products marketing and strategic planning. He previously held product management positions at General Foods and senior marketing management positions at Teradyne. -
James C. Kirk
March 25, 2009
Jim joined Eidetics in 1988 from senior management positions in consumer and industrial product marketing, strategy, and development positions at Ocean Spray Cranberries and Gillette Company. Previously at Ocean Spray, Jim successfully spearheaded the company’s new Ingredient Division. -
Frederick M. Gale, MD, FACS
March 25, 2009
A co-founder of Eidetics, Frederick brings over 20 years of experience in strategic research and consulting support for the pharmaceutical, biotech, and medical device industries. -
Jacco Keja, Ph.D.
March 25, 2009
Jacco joined Quintiles Consulting in 2007 as Practice Leader, Market Access. Previously, Jacco was responsible for building Organon's global and local competence in Strategic and Operational Pricing, as well as expanding Health Economics and Outcomes Research. -
John Doyle, Dr. PH
March 25, 2009
John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. -
Matthew Eberhart
March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.
Page 1 of 1 (9 items)